First published online March 2, 2007
Journal of Experimental Biology 210, 1036-1045 (2007)
Published by The Company of Biologists 2007
doi: 10.1242/jeb.02719
Activation and nuclear translocation of ERK in response to ligand-dependent and -independent stimuli in liver and gill cells from rainbow trout
Hannes L. Ebner,
Michael Blatzer,
Muhammad Nawaz and
Gerhard Krumschnabel*
Institut für Zoologie und Limnologie, and Center of Molecular
Biosciences, Leopold Franzens Universität Innsbruck,
Technikerstraße 25, A-6020 Innsbruck, Austria

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 1. Amino acid alignment of trout tMEK, deduced from the determined complete
coding region of the nucleotide sequence, and carp cMEK1 isoform (GenBank
accession no. AB063390), human hMAP2K2 (BC018645), rat rMAP2K2 (NM_205388),
and carp cMKK4 (AB063389). Specific protein interaction sites indicated are:
putative MAPK docking site (amino acids 127; underlined), NES-sequence
(AA 3647, boxed), and catalytic domain (AA 70364, grey
background); amino acid numbering refers to trout MEK.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2. Dynamics of ERK phosphorylation in primary hepatocytes (A), RTgill-W1 cells
(B) and RTH-149 hepatoma cells (C) from rainbow trout exposed to
hypo-osmolarity, 30 nmol l1 EGF or 10 µmol
l1 CuCl2, for up to 60 min as indicated. Numbers
below the blots are changes in pERK abundance, expressed relative to controls
at time zero, denoted as means ± s.e.m. of at least 3 independent
experiments. *Statistically significant difference from the control value, as
assessed on non-normalized data (P<0.05). c60', controls
incubated in standard conditions for 60 min. Activated ERK was determined by
western blot analysis using an antibody against the dually phosphorylated form
of ERK. The main band detected with this antibody migrated at approximately 44
kDa. In A, the second panel shows an example of a western blot analysis of
total ERK abundance using an antibody against the phosphorylated and
non-phosphorylated form of ERK (tERK). Similar analyses were made for all cell
types under all conditions and indicated that ERK abundance was not altered by
the treatments over the time course studied.
|
|

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 3. Cellular distribution of phosphorylated ERK in primary hepatocytes (A),
RTgill-W1 cells (B) and RTH-149 hepatoma cells (C) from rainbow trout
stimulated by exposure to hypo-osmolarity (Hypo), EGF or Cu, in the absence or
presence of leptomycin B (LB), as indicated. Cells were stained with an
antibody against the dually phosphorylated form of ERK and a FITC-labelled
secondary antibody and were then examined by confocal laser scanning
microscopy. The right panel in the top row in A shows a negative control
(Neg.) stained in the absence of the primary antibody. Scale bars, 20 µm
(valid for all images in B and C).
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4. Quantitative estimation of nuclear translocation of phosphorylated ERK in
RTgill-W1 cells, as determined from the ratio of staining intensity measured
in the nucleus to that of a cytoplasmic region of the cells. (A) Time course
of the change in nuclear/cytoplasmic ratio following the addition of EGF is
shown in controls and in cells after pre-incubation with leptomycin B. Values
are means ± s.e.m. of at least 20 cells from 23 independent
cultures. (B) Nuclear/cytoplasmic fluorescence ratio of cells after exposure
to hypo-osmotic shock, EGF or Cu at the time where the maximum increase of
relative nuclear fluorescence was determined (5' or 15'). Values
are means ± s.e.m. of at least 16 cells from 23 independent
cultures. Asterisks indicate a statistical significant difference
(P<0.05) from the value at time zero (A) or from cells in the
absence of LB (B).
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5. (A) Dynamics of MEK phosphorylation, determined by western blotting, in
RTgill-W1 cells exposed to 30 nmol l1 EGF for up to 60 min.
Figures below the blot indicate changes in pMEK abundance, expressed relative
to controls at time zero, and denote means ± s.e.m. of four independent
experiments. c60, controls incubated in standard conditions for 60 min. (B)
Cellular distribution of pMEK in RTgill-W1 cells incubated in standard
conditions or exposed to EGF for 5 min. The right image shows cells
pre-incubated with leptomycin B (LB) for 60 min prior to addition of EGF.
Cells were stained with an antibody against the dually phosphorylated form of
MEK and a FITC-labelled secondary antibody and were then examined by confocal
laser scanning microscopy. Scale bar, 20 µm (valid for all three images).
(C) Quantitative estimation of nuclear/cytoplasmic distribution of
phosphorylated MEK, expressed as nuclear/cytoplasmic ratio, in RTgill-W1 cells
exposed to EGF with or without prior pre-incubation with LB. Values are means
± s.e.m. of at least 14 cells from three independent cultures. For both
treatments, nuclear/cytoplasmic ratio is significantly decreased at all time
points compared to the value at time zero (P<0.05).
|
|
© The Company of Biologists Ltd 2007